# Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.

> **NCT06387901** · — · RECRUITING · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer
- Paclitaxel Adverse Reaction
- Chemotherapeutic Toxicity
- Chemotherapeutic Agent Toxicity
- Body Weight
- Physical Inactivity

## Interventions

- **DRUG:** Paclitaxel Chemotherapy

## Key facts

- **NCT ID:** NCT06387901
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-30
- **Primary completion:** 2025-05-06
- **Final completion:** 2025-10-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-11-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06387901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06387901, "Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06387901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*